Question 1

The first-line therapy for mild-persistent asthma is:

Accepted Answer

A)  High-dose montelukast 
B)  Theophylline 
C)  Low-dose inhaled corticosteroids 
D)  Long-acting beta-2-agonists 
A)  High-dose montelukast 
B)  Theophylline 
C)  Low-dose inhaled corticosteroids 
D)  Long-acting beta-2-agonists C

Question 2

Prior to developing a plan for the treatment of asthma, the patient's asthma should be classified according to the NHLBI Expert Panel 3 guidelines. In adults mild-persistent asthma is classified as asthma symptoms that occur:

Accepted Answer

A)  Daily 
B)  Daily and limit physical activity 
C)  Less than twice a week 
D)  More than twice a week and less than once a day 
A)  Daily 
B)  Daily and limit physical activity 
C)  Less than twice a week 
D)  More than twice a week and less than once a day D

Question 3

Patients with a COPD exacerbation may require:

Accepted Answer

A)  Doubling of inhaled corticosteroid dose 
B)  Systemic corticosteroid burst 
C)  Continuous inhaled beta-2-agonists 
D)  Leukotriene therapy 
A)  Doubling of inhaled corticosteroid dose 
B)  Systemic corticosteroid burst 
C)  Continuous inhaled beta-2-agonists 
D)  Leukotriene therapy B

Question 4

A stepwise approach to the pharmacologic management of asthma:

Accepted Answer

A)  Begins with determining the severity of asthma and assessing asthma control 
B)  Is used when asthma is severe and requires daily steroids 
C)  Allows for each provider to determine their personal approach to the care of asthmatic patients 
D)  Provides a framework for the management of severe asthmatics, but is not as helpful when patients have intermittent asthma 
A)  Begins with determining the severity of asthma and assessing asthma control 
B)  Is used when asthma is severe and requires daily steroids 
C)  Allows for each provider to determine their personal approach to the care of asthmatic patients 
D)  Provides a framework for the management of severe asthmatics, but is not as helpful when patients have intermittent asthma

Question 5

Asthma exacerbations at home are managed by the patient by:

Accepted Answer

A)  Increasing frequency of beta-2-agonists and contacting their provider 
B)  Doubling inhaled corticosteroid doses 
C)  Increasing frequency of beta-2-agonists 
D)  Starting montelukast (Singulair) 
A)  Increasing frequency of beta-2-agonists and contacting their provider 
B)  Doubling inhaled corticosteroid doses 
C)  Increasing frequency of beta-2-agonists 
D)  Starting montelukast (Singulair)

Question 6

One goal of asthma therapy outlined by the NHLBI Expert Panel 3 guidelines is:

Accepted Answer

A)  Ability to use albuterol daily to control symptoms 
B)  Minimize exacerbations to once a month 
C)  Keep nighttime symptoms at a maximum of twice a week 
D)  Require infrequent use of beta 2 agonists (albuterol) for relief of symptoms 
A)  Ability to use albuterol daily to control symptoms 
B)  Minimize exacerbations to once a month 
C)  Keep nighttime symptoms at a maximum of twice a week 
D)  Require infrequent use of beta 2 agonists (albuterol) for relief of symptoms

Question 7

Education of patients with COPD who use inhaled corticosteroids includes:

Accepted Answer

A)  Doubling the dose at the first sign of a URI 
B)  Using their inhaled corticosteroid first and then their bronchodilator 
C)  Rinsing their mouth after use 
D)  Abstaining from smoking for at least 30 minutes after using 
A)  Doubling the dose at the first sign of a URI 
B)  Using their inhaled corticosteroid first and then their bronchodilator 
C)  Rinsing their mouth after use 
D)  Abstaining from smoking for at least 30 minutes after using

Question 8

Education for patients who use an inhaled beta-agonist and an inhaled corticosteroid includes:

Accepted Answer

A)  Use the inhaled corticosteroid first, followed by the inhaled beta-agonists. 
B)  Use the inhaled beta-agonist first, followed by the inhaled corticosteroid. 
C)  Increase fluid intake to 3 liters per day. 
D)  Avoid use of aspirin or ibuprofen while using inhaled medications. 
A)  Use the inhaled corticosteroid first, followed by the inhaled beta-agonists. 
B)  Use the inhaled beta-agonist first, followed by the inhaled corticosteroid. 
C)  Increase fluid intake to 3 liters per day. 
D)  Avoid use of aspirin or ibuprofen while using inhaled medications.

Question 9

In children age 5 to 11 years mild-persistent asthma is diagnosed when asthma symptoms occur:

Accepted Answer

A)  At nighttime one to two times a month 
B)  At nighttime three to four times a month 
C)  Less than twice a week 
D)  Daily 
A)  At nighttime one to two times a month 
B)  At nighttime three to four times a month 
C)  Less than twice a week 
D)  Daily

Question 10

Patients with COPD require monitoring of:

Accepted Answer

A)  Beta-2-agonist use 
B)  Serum electrolytes 
C)  Blood pressure 
D)  Neuropsychiatric effects of montelukast 
A)  Beta-2-agonist use 
B)  Serum electrolytes 
C)  Blood pressure 
D)  Neuropsychiatric effects of montelukast

Question 11

Patients who are at risk of a fatal asthma attack include patients:

Accepted Answer

A)  With moderate persistent asthma 
B)  With a history of requiring intubation or ICU admission for asthma 
C)  Who are on daily inhaled corticosteroid therapy 
D)  Who are pregnant 
A)  With moderate persistent asthma 
B)  With a history of requiring intubation or ICU admission for asthma 
C)  Who are on daily inhaled corticosteroid therapy 
D)  Who are pregnant

Question 12

Pregnant patients with asthma may safely use ________ throughout their pregnancy.

Accepted Answer

A)  Oral terbutaline 
B)  Prednisone 
C)  Inhaled corticosteroids (budesonide) 
D)  Montelukast (Singulair) 
A)  Oral terbutaline 
B)  Prednisone 
C)  Inhaled corticosteroids (budesonide) 
D)  Montelukast (Singulair)

Question 13

Treatment for mild intermittent asthma is:

Accepted Answer

A)  Daily inhaled medium-dose corticosteroids 
B)  Short-acting beta-2-agonists (albuterol) as needed 
C)  Long-acting beta-2-agonists every morning as a preventative 
D)  Montelukast (Singulair) daily 
A)  Daily inhaled medium-dose corticosteroids 
B)  Short-acting beta-2-agonists (albuterol) as needed 
C)  Long-acting beta-2-agonists every morning as a preventative 
D)  Montelukast (Singulair) daily

Question 14

Monitoring a patient with persistent asthma includes:

Accepted Answer

A)  Monitoring how frequently the patient has an upper respiratory infection (URI) during treatment 
B)  Monthly in-office spirometry testing 
C)  Determining if the patient has increased use of his or her long-acting beta-2-agonist due to exacerbations 
D)  Evaluating the patient every 1 to 6 months to determine if the patient needs to step up or down in their therapy 
A)  Monitoring how frequently the patient has an upper respiratory infection (URI) during treatment 
B)  Monthly in-office spirometry testing 
C)  Determining if the patient has increased use of his or her long-acting beta-2-agonist due to exacerbations 
D)  Evaluating the patient every 1 to 6 months to determine if the patient needs to step up or down in their therapy

Question 15

One goal of asthma management in children is:

Accepted Answer

A)  They independently manage their asthma 
B)  Participation in school and sports activities 
C)  No exacerbations 
D)  Minimal use of inhaled corticosteroids 
A)  They independently manage their asthma 
B)  Participation in school and sports activities 
C)  No exacerbations 
D)  Minimal use of inhaled corticosteroids

Question 16

Medications used in the management of patients with chronic obstructive pulmonary disease (COPD) include:

Accepted Answer

A)  Inhaled beta-2-agonists 
B)  Inhaled anticholinergics (ipratropium) 
C)  Inhaled corticosteroids 
D)  All of the above 
A)  Inhaled beta-2-agonists 
B)  Inhaled anticholinergics (ipratropium) 
C)  Inhaled corticosteroids 
D)  All of the above

Exam 30: Asthma and Chronic Obstructive Pulmonary Disease

The first-line therapy for mild-persistent asthma is:

Prior to developing a plan for the treatment of asthma, the patient's asthma should be classified according to the NHLBI Expert Panel 3 guidelines. In adults mild-persistent asthma is classified as asthma symptoms that occur:

Patients with a COPD exacerbation may require:

A stepwise approach to the pharmacologic management of asthma:

Asthma exacerbations at home are managed by the patient by:

One goal of asthma therapy outlined by the NHLBI Expert Panel 3 guidelines is:

Education of patients with COPD who use inhaled corticosteroids includes:

Education for patients who use an inhaled beta-agonist and an inhaled corticosteroid includes:

In children age 5 to 11 years mild-persistent asthma is diagnosed when asthma symptoms occur:

Patients with COPD require monitoring of:

Patients who are at risk of a fatal asthma attack include patients:

Pregnant patients with asthma may safely use ________ throughout their pregnancy.

Treatment for mild intermittent asthma is:

Monitoring a patient with persistent asthma includes:

One goal of asthma management in children is:

Medications used in the management of patients with chronic obstructive pulmonary disease (COPD) include:

The Role of the Nurse Practitioner

Review of Basic Principles of Pharmacology

Rational Drug Selection

Legal and Professional Issues in Prescribing

Adverse Drug Reactions

Factors That Foster Positive Outcomes

Cultural and Ethnic Influences in Pharmacotherapeutics

An Introduction to Pharmacogenomics

Nutrition and Nutraceuticals

Herbal Therapy and Nutritional Supplements

Information Technology and Pharmacotherapeutics

Pharmacoeconomics

Over-The-Counter Medications

Drugs Affecting the Autonomic Nervous System

Drugs Affecting the Central Nervous System

Drugs Affecting the Cardiovascular and Renal Systems

Drugs Affecting the Respiratory System

Drugs Affecting the Hematopoietic System

Drugs Affecting the Immune System

Drugs Affecting the Gastrointestinal System

Drugs Affecting the Endocrine System

Drugs Affecting the Reproductive System

Drugs Affecting the Integumentary System

Drugs Used in Treating Infectious Diseases

Drugs Used in Treating Inflammatory Processes

Drugs Used in Treating Eye and Ear Disorders

Anemia

Chronic Stable Angina and Low-Risk Unstable Angina

Anxiety and Depression

Contraception

Dermatologic Conditions

Diabetes Mellitus

Gastroesophageal Reflux and Peptic Ulcer Disease

Headaches

Heart Failure

Human Immunodeficiency Virus Disease and Acquired Immunodeficiency Syndrome

Hormone Replacement Therapy and Osteoporosis

Hyperlipidemia

Hypertension

Hyperthyroidism and Hypothyroidism

Pneumonia

Smoking Cessation

Sexually Transmitted Infections and Vaginitis

Tuberculosis

Upper Respiratory Infections, Otitis Media, and Otitis Externa

Urinary Tract Infections

Women As Patients

Men As Patients

Children As Patients

Geriatric Patients

Pain Management: Acute and Chronic Pain

Filters